MarketsStocksBRAWN
BR

Brawn Biotech Ltd

NSE: BRAWNBSE: 530207Healthcare
Download Research Report7-page PDF
21.05
+0.00%
NSE · auto-updates while market open
Mkt Cap
₹6 Cr
P / E
6.6
P / B
1.5
ROE
-3.6%
52W High
₹24.37
52W Low
₹16.15
Key Metrics
Market Cap
₹6 Cr
P / E
6.63
P / B
1.46
EV / EBITDA
-
ROCE
-2.9%
ROE
-3.6%
Debt / Equity
0.00
Book Value
₹14.46
EPS
₹3.26
Div Yield
0.0%
Face Value
-
Promoter Holding
52.9%
Revenue · ₹ Cr
50
FY20
35
FY21
9
FY22
22
FY23
16
FY24
13
FY25
17
FY26
Net Profit · ₹ Cr
1
1
-1
-2
-1
-2
-2
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹4.6
₹2.0
₹3.3
₹-1.6
₹-5.3
₹-3.0
₹-5.1
FY19FY20FY21FY22FY23FY24FY26
Q4 2025 snapshot
Sales
₹4 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.17
Scorecard · 7 axes
Quality
Weak
33/100
Valuation
Strong
6.6×
Growth
Bad
-15.3%
Profitability
Bad
-3.3%
Performance
Good
+28.0%
Entry Point
Avg
86%
Red Flags
Strong
0 flags
Shareholding Pattern
52.9%Promoter
Promoter52.9%
DII0.3%
Public46.7%
Quarterly Results · ₹ Cr
QuarterFY24 09QFY24 12QFY25 03QFY25 06QFY25 09QFY25 12Q
Revenue3.33.852.355.894.984.4
Net Profit-0.344-0.432-0.4940.2360.0710.05
NPM %-10.4%-11.2%-21.0%4.0%1.4%1.1%
AlertPre-trade